Akèy › Kansè orofaringe › Oklahoma › Oklahoma City
Etid klinik pou Kansè orofaringe nan Oklahoma City, OK
3 etid pou Kansè orofaringe ap chèche patisipan nan sit nan ak bò kote Oklahoma City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
Ap rekriteFaz 2
- University of Oklahoma Health Sciences Center, Oklahoma City
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Ap rekriteFaz 2
- University of Oklahoma Health Sciences Center, Oklahoma City
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Ap rekriteFaz 2
- University of Oklahoma Health Sciences Center, Oklahoma City
Etid Kansè orofaringe nan lòt vil
- Atlanta, GA8 etid
- Edison, NJ8 etid
- Chicago, IL7 etid
- New York City, NY6 etid
- Queens, NY5 etid
- St. Louis, MO5 etid
- Tampa, FL5 etid
- Kansas City, MO5 etid
- Omaha, NE5 etid
- Philadelphia, PA5 etid
- Milwaukee, WI5 etid
- Los Angeles, CA5 etid
Lòt etid nan Oklahoma City
- Kansè Poumon ki pa ti selil28 etid
- Kansè ovè28 etid
- Kansè Endomèt25 etid
- Kansè kolorektal22 etid
- Kansè pwostat21 etid
- Kansè poumon19 etid
- Kansè nan tete17 etid
- Kansè Metastatik16 etid
- Kansè (tout kalite)14 etid
- Leksemi mieloïd egi14 etid
- Karsinòm selil skuamèz tèt ak kou13 etid
- Kansè vejik11 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.